• Tidak ada hasil yang ditemukan

(Examples include all individual participant data after deidentification, only participant data that underlies the results, or not available.) N/A 55 What other documents will be available

N/A
N/A
Protected

Academic year: 2023

Membagikan "(Examples include all individual participant data after deidentification, only participant data that underlies the results, or not available.) N/A 55 What other documents will be available"

Copied!
1
0
0

Teks penuh

(1)

K

ELLY ET AL

.

O

PERATIVE

V

ERSUS

N

ONOPERATIVE

T

REATMENT FOR

A

DULT

S

YMPTOMATIC

L

UMBAR

S

COLIOSIS

http://dx.doi.org/10.2106/JBJS.18.00483

Question Text Author

Response

Custom Submission Question ID

Please complete the following questions in accordance with the International

Committee of Medical Journal Editors’ recommendations on data sharing in clinical trials (guidelines and examples are available here).

Will individual participant data be available (including data dictionaries)?

no 54

What data in particular will be shared?

(Examples include all individual participant data after deidentification, only participant data that underlies the results, or not available.)

N/A 55

What other documents will be available? N/A 56

When will data be available (start and end dates)? N/A 57

With whom? (Examples include anyone who wishes to access the data, researchers

who provide a proposal, or not applicable.) N/A 58

For what types of analyses? N/A 59

By what mechanism will data be made available? N/A 60

Referensi

Dokumen terkait

Judul yang penulis ajukan adalah “ANALISIS KINERJA KEUANGAN DENGAN MENGGUNAKAN RATIO RETURN ON ASSET (ROA) DAN RETURN ON EQUITY (ROE) PADA PT.BANK RAKYAT

ARANDOMIZED TRIAL OF STATIC AND ARTICULATING SPACERS FOR THE TREATMENT OF INFECTION FOLLOWING TOTAL KNEE ARTHROPLASTY http://dx.doi.org/10.2106/JBJS.19.00915 Question Text Author